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Abstract We used a PCR-based subtraction cloning procedure with Concanavalin A-treated and untreated animal caps from stage 9 Xenopus 
embryos to search for genes the expression of which is induced uring neurogenesis. One of these genes was found to encode a homolog of mammalian 
HMG 1 and 2, hence named HMG-X. HMG-XmRNA was maternally transmitted, up-regulated in neuroectoderm-derived tissues throughout early 
development, and eventually down-regulated in all adult issues examined except ovary. Our data suggest that we have identified a gene for a member 
of the HMG1/2 family that could have an important role in neurogenesis. 
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1. Introduction 
Recent studies have led to the identification of some of the 
endogenous molecules, such as activin [l] and noggin [2], in- 
volved in the process of neural induction in Xenopus embryo. 
The signals elicited by these inducers must eventually be trans- 
mitted into the nucleus of ectodermal cells and alter their gene 
expression; however, the molecular events in this later step of 
neural induction remain largely obscure. 
The mammalian high mobility group proteins, HMGl and 
2, are known as non-histone nuclear proteins which are ubiqui- 
tously expressed and display a high degree of conservation 
across species, implying their role in some fundamental biolog- 
ical process. They have been postulated to be a structural com- 
ponent of chromatin or to operate as DNA chaperones [3-51. 
Furthermore, roles in replication, repair and recombination 
have been suggested since the HMG proteins bind to DNA in 
a sequence non-specific manner, preferentially to single- 
stranded DNA [6]. The HMGlR may also play a role in gene 
regulation by inducing conformational changes in DNA [7,8] 
and facilitating cooperative interactions between &-acting ele- 
ments and sequence-specific DNA-binding proteins [9-l 11. 
Here we have attempted to identify genes up-regulated after 
neural induction of Xenopus ectoderm in vitro, and isolated a 
cDNA encoding a protein (designated HMG-X) exhibiting a 
high degree of homology to mammalian HMGl and 2. 
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2. Materials and methods 
2. I. Neural induction in animal caps 
Eggs of Xenopus laevis were obtained as described [12]. Embryos 
were staged according to Nieuwkoop and Faber [13]. Eighty animal 
caps from stage 9 embryos were incubated for the initial 3 h with or 
without 500 &ml of Con A using a modification of the method of 
neural induction reported by Takata et al. [14] and Grunz [15], which 
will be described elsewhere in detail (Hatada et al., in preparation). 
Neural induction in sampled animal caps was confirmed after 3 days 
by direct microscopic observation of brain-like structures (Fig. 1) and 
immunohistochemistry with monoclonal antibody NEU-I directed 
against neuronal cells [6] (data not shown). 
2.2. Construction of PCR-based directional library 
Approximately 30 ng of poly(A)’ RNA obtained from induced 
(+) and uninduced (-) animal caps was reverse transcribed using the 
primer 5‘-GAGAGAGACCCGGGACGATGAGCTGTGAATCTC- 
GAG(T),,-3’. After second strand synthesis [l7] and blunt-ending, 
Ml&linkers, prepared by annealing the oligos 5’-GGACTATGTGA- 
CGCGTATGG-3’ and 5’-pCCATACGCGTCACATAG-3’, were li- 
gated to the ends of the cDNAs. After SmaI digestion, the excess linkers 
and DNA fragments of less than 400 bp were removed by gel-filtration. 
The larger DNA was amplified by PCR for library construction and 
for probes for use in differential screening (see below) using the primers 
5’-GGACTATGTGACGCGTATGG-3’ and 5’-GACGATGAGCT- 
CTGATCTCGJ’. The reaction mixture was first incubated at 96°C for 
5 min and subjected to 30 cycles of PCR (1 min at 96°C 1 min at 55°C 
and 2 min at 67’C). A second round of PCR (additional 30 cycles in 
fresh reaction mixture) was performed using one-tenth of the initial 
amplification product. The cDNA of more than 400 bp selected by 
agarose gel-electrophoresis was digested with MIuI and XhoI, and then 
directionally cloned between the corresponding sites of the 
pGEM7Zf(-) vector (Promega). 
2.3. Subtractive hybridization and differential screening 
Using a modification of the method reported by Rubenstein [l8], 
1 pg of single-stranded antisense DNA (ssDNA) from the (+) library 
was subtracted twice with 2Opg of sense RNA in vitro transcribed from 
the (-) library with 5% UTP-biotin (Clontech) in unmodified UTP. The 
remaining DNA was subjected to 30 cycles of PCR using above set of 
primers, and cloned into pGEM7Zf(-). This sub-library consists of 
approximately 30,000 clones. We have screened about 2,000 clones 
using “P-labeled probes generated by PCR from the (+) and (-) tem- 
plates described above. Candidate cDNAs for differentially expressed 
genes were further examined by Northern blot hybridization using total 
RNA extracted from Con A-treated and untreated animal caps. 
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Cloning and sequence analysis of HMG-X cDNA 
Ve screened a unidirectional embryonic DNA library which we had 
strutted earlier using standard techniques [12] with a cDNA probe 
Ine #12) obtained from our PCR-based subtraction procedure. The 
leotide sequence of clone #12.9 (approximately 1.2 kb) was deter- 
led and has been submitted to the DDBJ, EMBL and GenBank 
abases under accession umber D30765. Structural homology was 
lyzed using TFASTA and PILEUP [19] obtained from Wisconsin 
letics Computing Group. 
Northern blot hybridization 
L 1.2 kb EcoRI-XhoI fragment excised from clone #12.9 was used 
template for making HMG-Xprobes. For controls, PCR-generated 
VA fragments of Xenopus C-SK [20] and EF-la. [21] were used. 
bridization and densitometry were performed as described [12]. 
Whole-mount in situ hybridization 
jigoxigenin (DIG)-labeled RNA probes in sense and antisense ori- 
xtions were prepared from clone #12.9 using the DIG RNA Label- 
Kit (Boehringer). The probe size was reduced to approximately 200 
by limited alkaline hydrolysis. Whole-mount in situ hybridization 
i performed essentially as described [22]. 
Results 
. Isolation of cDNA clones up-regulated in animal caps during 
neural development 
\Teural tissue-like structures such as neural tubes, with or 
hout eyes, were induced in about 90% of the animal caps 
lays after Con A treatment, while only ciliated epithelial 
;ues were formed in untreated samples (Fig. 1). 
)oly(A)’ RNA extracted from the Con A-treated and un- 
ated animal caps was amplified by RNA-PCR and used for 
lstructing unidirectional cDNA libraries (designated (+) and 
library, respectively). The average size of the inserts esti- 
ted by random sampling was about 420 bp (range, 400-600 
1. Single-stranded DNA from the (+) library was subtracted 
h biotinylated RNA transcribed from the (-) library. A 
rtion of the resulting sub-library was subjected to differential 
eening using radiolabeled, PCR-amplified cDNAs from Con 
treated and untreated animal caps. Among 2,000 clones ran- 
mly picked from the sub-library, 43 clones gave significantly 
onger signals with the probe from Con A-treated animal 
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caps. Sequencing and database searches for these ‘up-regulated’ 
clones revealed that two of them, #12 (ca. 200 bp) and #14 
(ca. 180 bp), contained novel sequences. Most of the other 
clones were derived from RNA species especially abundant in 
embryo, such as tRNAs, 12 S rRNA, and mRNA for EF-la. 
3.2. Clone #I2 encodes a protein similar to mammalian HMGI 
and 2 
We screened a previously constructed unidirectional total 
embryonic cDNA library [12] with a cDNA probe based on 
clone #12 and obtained 13 positive clones out of 50,000 pla- 
ques. We determined its total sequence of the longest cDNA, 
clone #12.9 (Fig. 2A). The cDNA consists of 1080 bp and 
contains a single, long open reading frame of 636 bp preceded 
by three in-frame termination codons. The first methionine in 
the open reading frame is in a context appropriate for transla- 
tion initiation [23], and the predicted protein product consists 
of 212 amino acids with a calculated molecular mass of about 
24,200. There are two mRNA-destabilizing signals, ATTTA 
[24], in the 3’ non-coding region. A database search with the 
predicted amino acid sequence revealed that it shares a high 
degree of homology with mammalian HMGl and 2, as well as 
trout HMG-T; hence we named it HMG-X (Fig. 2B). HMG-X 
has the canonical primary structure of an HMG1/2 family pro- 
tein, consisting of two repeats of the HMG box [25] and a 
carboxy-terminal acidic tail. 
3.3. Expression of HMG-X mRNA 
A 1.2 kb transcript of HMG-X was detected in embryos at 
stages O-35 by Northern blot hybridization (Fig. 3A). Since 
zygotic transcription is not active until the midblastula transi- 
tion [26], the signals detected both in the ovary and stages O-6 
embryo strongly suggests maternal transmission of HMG-X 
mRNA, although the transcript size of the latter is slightly 
larger, possibly because of elongation of the poly(A) tail as has 
been observed for the non-histone protein B4 [27]. As com- 
pared to the relatively invariable expression of c-src [28], HMG- 
X was up-regulated after stage 8 and peaked around stage 
12-14, followed by down-regulation at stage 20-25 and up- 
;. 1. Neural induction of animal caps with Con A. (A) Animal caps treated with Con A formed a neural tube-like structure after 3 days. (B) Untreated 
lmal caps formed a ciliated epithelial cell mass. 
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Fig. 2. Structure of HMG-X cDNA and its encoded protein. (A) Nucleotide sequence of the #12.9 cDNA and predicted amino acid sequence. Three 
in-frame termination codons preceding the first methionine are boxed. The two mRNA-destabilizing signals are underlined, and the polyadenylation 
signal is double-underlined. (B) Alignment of HMG112 family protein sequences. The amino acid residues identical between HMG-X and each 
homolog are indicated by a dash (-). 
regulation again at stage 35 (Fig. 3B). In all the adult tissues 
examined, except for the ovary, two faint bands of about 2 kb 
and 1.2 kb were identified (Fig. 3C). The 2 kb transcript was 
not seen in adult ovary or embryonic samples. 
HMG-X mRNA expression was further analyzed by whole- 
mount in situ hybridization with embryos at various stages of 
development (Fig. 4A-J). In the blastula (stage lo), weak sig- 
nals of HMG-X expression were detected in the animal hemi- 
sphere (Fig. 4A). In the late gastrula (stage 12), the transcript 
was detected throughout the ectodetm (Fig. 4B). At this stage 
the ectoderm covers the entire surface of the embryo except for 
the yolk plug. In the early neurula (stage 15), the signal was 
detected throughout he neural plate, except for areas along the 
midline (Fig. 4C and D). In the tailbud (stage 22), expression 
was seen along the neural tube and its derivatives, including 
optic and otic vesicles, as well as some non-neural tissues such 
as the branchial arch anlagen (Fig. 4E and F). In stage 25 larva, 
signals along the neural tube were diminished especially in the 
middle part of the body, while expression remained intense in 
brain, optic and otic vesicles, branchial arches and tail bud (Fig. 
4G and H). In stage 32 tadpoles, signals were found in the 
differentiating nervous system, including brain, eyes, ears, spi- 
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A 
HMG-X 
c-src 
nal cord and intercostal nerves, and also in the branchial arches 
and tail (Fig. 41 and J). Apparently, the total signal level at this 
stage was more than that at stage 25, consistent with the up- 
regulation from stage 25 to 32 on the Northern blot analysis. 
No signals were seen in the notochord or cement gland 
throughout development up to stage 32, which was confirmed 
by observing axial sections of the hybridized samples (data not 
shown). Control samples hybridized with the HMG-X sense 
probe showed no detectable signals in any of the stages (data 
not shown). 
stage 0 6 8 10 12 14 16 18 20 25 35 
B 
C 
0 6 8 10 12 14 16 18 20 25 35 
stage 
Fig. 3. Expression of HMG-X mRNA in Xenopus embryos and adult 
tissues. (A) Northern blot analysis. Each lane contained 2.5 pg of poly 
(A)’ RNA isolated from whole embryos. (B) Densitometric analysis of 
the data presented in (A). The shaded and black bars represent intensi- 
ties of the HMG-X and C-SK bands, respectively. The bent line indicates 
their ratio. (C) Northern blot analysis. Each lane contained 2.5 fig of 
poly(A)’ RNA from adult Xenopus tissues and whole embryos for 
comparison. The open and filled arrowheads indicate the 2.0- and 
1.2-kb transcript, respectively. 
4. Discussion 
We have shown that HMG-X mRNA is likely to be mater- 
nally transmitted and is highly expressed in neuroectoderm- 
derived tissues during embryogenesis and in the adult ovary, 
that the xpression of HMG-X gene is regulated in a tissue- and 
stage-specific manner, and that its expression pattern cannot be 
explained solely on the basis of the growth activity or the origin 
of the cells. Interestingly, down-regulation of HMGl protein 
in rat myoblast cell lines during in vitro myogenesis has been 
reported [29], supporting, albeit indirectly, the idea of stage- 
specific expression of the HMGlI2 family of genes. These find- 
ings are not compatible with the idea that sequence-specific 
HMG proteins are cell-type specific, while sequence non-spe- 
cific HMG proteins are ubiquitous [3]. Since more than one 
HMGlI2 family of genes are found in the genomes of Droso- 
phila and Saccharomyces cerevisiae, it seems reasonable to pre- 
dict that additional HMGl/2-related gene(s) in Xenopus may 
also show a distinct tissue- and stage-specific expression pat- 
tern. The bulk of earlier evidence suggests that HMGl and 2 
do not recognize specific DNA sequences but rather exert their 
function by somehow regulating the activities of other, se- 
quence-specific DNA-binding proteins such as progesterone 
receptor [30]. If this is the case, HMG-X protein could partici- 
pate in neural fate determination by regulating, through modu- 
lation of chromatin configuration, the ability of transcription 
factors to induce the expression of a specific set of genes. Our 
preliminary microinjection experiments indicated that over-ex- 
pression of HMG-X mRNA in the 2-cell-stage mbryo was not 
sufficient to induce neural tissue ectopically (unpublished). 
However, our negative results with wild-type HMG-X mRNA 
do not rule out a regulatory role of its product in neural devel- 
opment. 
The molecular mechanism of Con A action on neural induc- 
tion in Xenopus animal caps is far from clear. The possibility 
cannot be excluded that an unidentified impurity in the Con A 
preparations might actually be the active principle (unpub- 
lished). In light of the recent findings that inhibition of the 
activin signal results in neural induction [3 11, possibly the active 
Fig. 4. Whole-mount in situ hybridization analysis of HMG-X mRNA in Xenopus embryos. (A) Vegetal view of a stage 10 embryo (blastula) showi; 
minimal expression in vegetal hemisphere. (B) Vegetal view of a stage 12 embryo (late gastrula). HMG-X is expressed throughout he ectoderm but 
not in the yolk plug (arrowhead). Note that the signal is more intense in the dorsal region (presumptive neuroectoderm) than in the ventral region 
(presumptive pidermal ectoderm). (C) Dorsal and (D) lateral views of a stage 15 embryo (neurula), showing expression along the neural plate and 
in head and tail regions. Note the minimal expression along the midline and down-regulated expression in non-neural ectoderm. (E) Lateral and 
(F) anterior views of a stage 22 embryo (tailbud), showing intense expression along the neural tube, optic vesicles (arrowhead), branchial (arrow) 
and tail regions. (G) Lateral and (H) dorsal views of a stage 25 embryo. Expression in the middle part of the neural tube was reduced (arrowheads). 
(I) Lateral view of a stage 32 embryo, showing intense expression in the head organs and tail. (J) Higher magnification of (I). Note the expression 
along the intercostal nerves (arrows). a, anterior; p, posterior; d, dorsal; v, ventral; br, brain; ey, optic vesicle and eye; ov, otic vesicle; ba, branchial 
arches; cg, cement gland; SC, spinal cord; in, intercostal nerves. 
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)le in the Con A preparation interferes with the activin 
ng pathway. Another possibility is that it might activate 
I kinase C, resulting in neural induction [32]. Thus the 
event in neural induction using this system is unknown; 
heless, we consider this in vitro neural induction system 
1 source of presumptive neuroectoderm undergoing de- 
ation and development oward neural tissues in a syn- 
zed manner. Another merit of using the Xenopus system 
we can follow the expression patterns of isolated genes 
early embryo by whole-mount in situ hybridization and 
eir activity by injecting the mRNAs. It has been found 
:MG-2 protein is down-regulated uring brain develop- 
n the rat [33], however, no information about its expres- 
uring early embryogenesis has been available. 
aining large quantities of animal caps undergoing syn- 
ms neural development did not prove practical. In order 
rcome this obstacle we employed a PCR-based subtrac- 
oning strategy. However, one of the drawbacks in this 
ich was that we had to use PCR-amplified cDNA and 
e that all the mRNA species were amplified to the same 
, which may not always have been the case. Out of 2,000 
screened, we found two clones (#12 described here and 
he expression of which is prominently up-regulated ur- 
: neural induction in vitro. Clone #14 was recently found 
ode a glutamine synthase (unpublished data), a homolog 
ch is highly induced in glial cells during development of 
atina [34]. The majority of the clones obtained, however, 
ne relatively abundant genes with fundamental functions. 
stance, EF-la mRNA is markedly up-regulated during 
us embryogenesis [21], while the amount of 12 S rRNA 
.riable [35]. Therefore some of the abundant cDNA spe- 
em to have been preferentially amplified by PCR. Never- 
;, this approach worked well and we expect to obtain 
up-regulated’ clones from the libraries we generated ur- 
s study (to date we have screened less than 7% of the total 
b-library). Characterization of such genes should yield 
information about the changes in gene activities during 
genesis. 
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